Alisa Negron

Healthcare Regulatory Analyst
Main
703-683-9600
, ext.
1455
Location
Alexandria, VA

Professional Experience

Alisa Negron provides critical regulatory insight, analysis and research across various compliance topics, synthesizing complex healthcare regulatory and industry information into actionable insights for consultants and clients. With a focus on federal and state healthcare laws, Ms. Negron delivers strategic guidance on key federal and healthcare regulations, proposed legislation and program rules, including HIPAA, HITECH Act, False Claims Act, Stark Law, Anti-Kickback Statute and Federal healthcare programs. 

She conducts in-depth research and analysis on emerging regulatory trends and legislative developments, translating complex legal language into actionable insights for clients and internal teams. Ms. Negronโ€™s contributions include drafting regulatory reports, compliance documentation, policy briefs, white papers, and client memos, ensuring that all content is accurate, timely, and tailored to meet the needs of diverse healthcare organizations. Additionally, in her role, Ms. Negron collaborates closely with consulting teams to support project execution across multiple engagements, develop educational materials, and deliver internal presentations on regulatory updates.

Previous Work Experience

Ms. Negron has served in multiple roles at the U.S. Department of Health and Human Services. At the Substance Abuse and Mental Health Services Administration (SAMHSA), she was a Presidential Management Fellow and Legislative Analyst, where she communicated center-level legislative priorities and tracked policy developments to inform senior leadership. At the National Institutes of Health (NIH), she contributed to the development of research programs and provided technical support to inform scientific research. Earlier in her career, Ms. Negron held internships at the Office of National Drug Control Policy (ONDCP) at the White House and the Centers for Disease Control and Prevention (CDC), where she supported federal public health initiatives at the intersection of policy, research, and practice.